CapsoVision (CV) Current Leases (2024 - 2025)
CapsoVision's (CV) quarterly Current Leases came in at $410000.0 in Q4 2025, up 16.81% year-on-year from $351000.0 in Q4 2024, and up 4.06% quarter-over-quarter from $394000.0 in Q3 2025.
CapsoVision (CV) Current Leases (2024 - 2025) Analysis & Trends
CapsoVision has disclosed Current Leases across 2 years of filings, most recently posting $410000.0 for Q4 2025.
- Current Leases for Q4 2025 came in at $410000.0, up 16.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $410000.0 (up 16.81% YoY), and the FY2025 annual result was $410000.0, up 16.81% from the prior year.
- Current Leases came in at $410000.0 for Q4 2025 at CapsoVision, up from $394000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $410000.0 in Q4 2025 to a low of $351000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 35.80 Mn |
| 10 | CapsoVision | 161.82 Mn | 151.71 Mn | 1.95 Mn | 410,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 410,000.00 |
| Sep 30, 2025 | 394,000.00 |
| Jun 30, 2025 | 379,000.00 |
| Dec 31, 2024 | 351,000.00 |